The Value of Serum Tumor Markers and Blood Inflammation Markers in Differentiating Pancreatic Serous Cystic Neoplasms and Pancreatic Mucinous Cystic Neoplasms.

Wang, Huan; Chen, Sihai; Shu, Xu; Liu, Zhijian; Liu, Pi; Zhu, Yong; Zhu, Yin; Xiong, Huifang

Wang, Huan; Chen, Sihai; Shu, Xu; Liu, Zhijian; Liu, Pi; Zhu, Yong; Zhu, Yin; Xiong, Huifang.

Afiliación

Wang H; The First Affiliated Hospital of Nanchang University, Nanchang, China.
Chen S; The First Affiliated Hospital of Nanchang University, Nanchang, China.
Shu X; The First Affiliated Hospital of Nanchang University, Nanchang, China.
Liu Z; The First Affiliated Hospital of Nanchang University, Nanchang, China.
Liu P; The First Affiliated Hospital of Nanchang University, Nanchang, China.
Zhu Y; The First Affiliated Hospital of Nanchang University, Nanchang, China.
Zhu Y; The First Affiliated Hospital of Nanchang University, Nanchang, China.
Xiong H; The First Affiliated Hospital of Nanchang University, Nanchang, China.

Front Oncol ; 12: 831355, 2022.

Article en En | MEDLINE | ID: mdl-35280794

Palabras clave

CA199; diagnose; mucinous cystic neoplasms; pancreatic cystic neoplasms; serous cystic neoplasms

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google